Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis

Clinical trial NCT07750574 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07750574
Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelofibrosis Myelofibrosis Due to and Following Polycythemia Vera Myelofibrosis Transformation in Essential Thrombocythemia Myelofibrosis With High Molecular Risk Mutations Myelofibrosis With Myeloid Metaplasia Myelofibrosis, Post ET Myelofibrosis, Post PV Myelofibrosis, Primary Myelofibrosis; Anemia Myelofibrosis，MF Myelofibrosis (PMF)Myeloid Metaplasia

Start date: 2026-11-01
Primary completion: 2028-11-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.